Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene
Phase 3
Completed
- Conditions
- Hygiene
- Registration Number
- NCT00370162
- Lead Sponsor
- Sanofi
- Brief Summary
The purpose of this study is to demonstrate the safety of the gynaecological formulation in normal and usual usage condition.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
- Integral skin in the tested region
Read More
Exclusion Criteria
- Pregnancy or breastfeeding women
- Use of antiinflammatory or immunosuppression drugs
- Topical medication use at the tested region
- Active cutaneous gynaecological disease
- Personal history of allergic disease at the area to be treated
- Allergic or atopic history
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Adverse Events and its association with the drug in study
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sanofi-Aventis
🇧🇷São Paulo, Brazil